PAM
RKDA icon

Panagora Asset Management’s Arcadia Biosciences RKDA Stock Holding History

Panagora Asset Management’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-86
Closed -$209K – 2349
2015
Q3 		$209K Buy
86
+62
+258% +$258K ﹤0.01% 1591
2015
Q2 		$120K Buy
+24
New +$149K ﹤0.01% 1895

Other funds holding RKDA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

Panagora Asset Management's RKDA Position: Q4 2015 in Review

Panagora Asset Management sold out of Arcadia Biosciences (RKDA) in Q4 2015, closing a stake of 86 shares — an estimated $209K sold.

Panagora Asset Management first reported a position in RKDA in Q2 2015 and held it in 2 quarters. The position peaked at $209K in Q3 2015. 26 funds tracked by Wall St. Rank hold RKDA as of Q4 2015.

  • Panagora Asset Management reported no remaining Arcadia Biosciences position as of Q4 2015 after selling out during the quarter.
  • Panagora Asset Management sold 86 Arcadia Biosciences shares in Q4 2015, an estimated $209K.
  • Panagora Asset Management first reported a position in Arcadia Biosciences in Q2 2015 and held it in 2 quarters.
  • Panagora Asset Management's Arcadia Biosciences position peaked at $209K in Q3 2015.
  • 26 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q4 2015.

Based on Panagora Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.